Domainex Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Domainex Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10837
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Domainex Ltd (Domainex) is a drug discovery service company that offers drug discovery programmes against a wide range of drug targets. The company provides services such as molecular biology / cdh, protein expression, assays, fragment screening, virtual screening, computational chemistry, medicinal chemistry, ADME and DMPK among others. The company’s discovery platform technology enables rapid progression of drug discovery projects from drug target through to candidate drug. It works in partnership with pharma and biotech companies and academic institutions to offer drug discovery expertise and services. Domainex is headquartered in Saffron Walden, the UK.

Domainex Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Domainex Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Domainex Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Domainex Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round 10
Partnerships 11
Dotmatics Enters into Agreement with Domainex 11
Johnson Matthey and Domainex Enter into Partnership 12
Domainex Expands its Agreement with Imperial College London 13
ZoBio and Domainex Enter into Agreement with Forma Therapeutics 14
Domainex Extends Co-Development Agreement with Auspherix 15
Horizon Discovery Enters Into Agreement With Domainex To Support Oncology Program 16
Domainex Ltd – Key Competitors 17
Domainex Ltd – Key Employees 18
Domainex Ltd – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Strategy And Business Planning 20
Jul 19, 2018: Domainex opens for business in Boston and San Diego 20
Corporate Communications 21
Sep 20, 2018: Domainex names Dr Trevor Perrior as Chief Executive Officer 21
Dec 06, 2017: Domainex appoints Chris Brown as Chief Financial Officer 22
Mar 30, 2017: Domainex appoints Timo Veromaa as Executive Chairman 23
Government and Public Interest 24
Jan 23, 2018: Domainex wins award to develop GPCR drug discovery technology 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Domainex Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Domainex Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Domainex Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Domainex Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round 10
Dotmatics Enters into Agreement with Domainex 11
Johnson Matthey and Domainex Enter into Partnership 12
Domainex Expands its Agreement with Imperial College London 13
ZoBio and Domainex Enter into Agreement with Forma Therapeutics 14
Domainex Extends Co-Development Agreement with Auspherix 15
Horizon Discovery Enters Into Agreement With Domainex To Support Oncology Program 16
Domainex Ltd, Key Competitors 17
Domainex Ltd, Key Employees 18

List of Figures
Domainex Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Domainex Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Domainex Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gulf Keystone Petroleum Ltd (GKP):企業の財務・戦略的SWOT分析
    Summary Gulf Keystone Petroleum Ltd (Gulf Keystone) is an oil and gas company that offers operation and production of oil and natural gas reserves. The company operates working interests in the Republic of Algeria and the Kurdistan Region of Northern Iraq. Its Kurdistan Region of Iraq operates produ …
  • Bank of Jordan (BOJX):企業の財務・戦略的SWOT分析
    Summary Bank of Jordan is a banking service provider. The company offers corporate services, leasing services, retail services, SMEs services and securities services. It also provides car loans, mortgage, personal loans and credit cards. Bank of Jordan’s retail services include accounts and deposits …
  • Itau Unibanco Holding SA:企業の戦略・SWOT・財務情報
    Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report Summary Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Amryt Pharma plc (AMYT):製薬・医療:M&Aディール及び事業提携情報
    Summary Amryt Pharma plc (Amryt) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for patients with rare and orphan diseases. It has two marketed products include Lojuxta for the treatment of adult HoFH and Episalvan for the treatment of PTW. The …
  • FibroGen Inc (FGEN):企業の財務・戦略的SWOT分析
    FibroGen Inc (FGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Relation Insurance Services, Inc:企業の戦略・SWOT・財務情報
    Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report Summary Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Thor Industries, Inc.:企業の戦略・SWOT・財務分析
    Thor Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Thor Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Galectin Therapeutics Inc (GALT):企業の財務・戦略的SWOT分析
    Summary Galectin Therapeutics Inc (Galectin Therapeutics), formerly Pro-Pharmaceuticals Inc is a biotechnology company that discovers, develops and commercializes therapies for fibrotic disease and cancer. The company provides products such as GR-MD-02, GM-CT-01, and others. Its GR-MD-02 is a drug c …
  • Total SA (FP)-石油・ガス分野:企業M&A・提携分析
    Summary Total S.A. (Total) is an integrated global oil and gas company that produces, refines and markets oil, and also manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distribution of petrole …
  • TOWER Limited:企業の戦略・SWOT・財務分析
    TOWER Limited - Strategy, SWOT and Corporate Finance Report Summary TOWER Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Rohto Pharmaceutical Co Ltd (4527):企業の財務・戦略的SWOT分析
    Rohto Pharmaceutical Co Ltd (4527) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Mymetics Corp (MYMX):製薬・医療:M&Aディール及び事業提携情報
    Summary Mymetics Corp (Mymetics) is a biotechnology company that develops next-generation prophylactic vaccines for infectious diseases. The company's product pipeline includes vaccine candidates that target HIV-1/AIDS, chikungunya, intranasal influenza, malaria, herpes simplex virus (HSV) and respi …
  • Time Technoplast Ltd:企業の戦略・SWOT・財務情報
    Time Technoplast Ltd - Strategy, SWOT and Corporate Finance Report Summary Time Technoplast Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Elmet Technologies Inc:企業の戦略・SWOT・財務分析
    Elmet Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Elmet Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Panhandle Oil and Gas Inc. (PHX)-石油・ガス分野:企業M&A・提携分析
    Summary Panhandle Oil and Gas Inc. (Panhandle) is an upstream oil and gas company that carries out exploration, development, production and sale of oil and natural gas. It is involved in the acquisition, management and development of non-operated oil and natural gas properties, including wells locat …
  • Elektroprivreda Crne Gore AD Niksic:電力:M&Aディール及び事業提携情報
    Summary Elektroprivreda Crne Gore AD Niksic (Elektroprivreda) is an electric utility service provider that generates, transmits, distributes, and supplies electricity to its consumers across Montenegro. The utility operates hydro and thermal power generation plants. It offers customer services such …
  • French National Institute of Health and Medical Research:医療機器:M&Aディール及び事業提携情報
    Summary French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immu …
  • QIMR Berghofer Medical Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary QIMR Berghofer Medical Research Institute (QIMR), formerly Queensland Institute of Medical Research is a medical research institute that offers education and research programs. The institute offers its research programs in the areas of mental health, cancer, infectious disease, and complex d …
  • Center for Applied Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary Center for Applied Medical Research (CIMA), a subsidiary of University of Navarra is a medical research center that carries out research in the therapeutic areas of cardiovascular sciences, gene therapy and hepatology, oncology and neurosciences. The center also provides support services suc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆